Essential Functions

• Provide strategic leadership and subject matter expertise across all medical physics and dosimetry activities for Perspective’s radioligand therapy (RLT) clinical programs, ensuring scientific rigor, quality, and regulatory compliance.
• Oversee and guide the development, implementation, and refinement of imaging and dosimetry protocols conducting analysis where necessary, collaborating with Clinical Development, Regulatory, and R&D to ensure alignment with clinical and program goals.
• Lead the establishment of best-in-class standards for imaging acquisition, reconstruction, and radiation dose assessment; proactively identify innovations and optimizations to improve accuracy, efficiency, and patient safety.
• Manage, mentor, and develop internal radiation sciences staff and external vendors/consultants where indicated and supporting clinical and translational dosimetry across sites and geographies.
• Serve as a senior liaison with key external stakeholders, including CROs, imaging core labs, clinical investigators, and regulatory authorities; represent Perspective in regulatory interactions, including contributing to IND, CTA, and NDA submissions.
• Oversee centralized quality control and assurance programs for dosimetry and imaging activities across all clinical trial phases and products; ensure harmonization of processes across study sites and company development programs.
• Drive the evaluation and adoption of novel technologies, systems, and software tools for imaging data handling, treatment planning, and dose calculation, with a focus on scalability and compliance.
• Collaborate with internal teams to assess and implement new radiopharmaceutical programs, contributing to pipeline decision-making with expertise in radiation biology and therapeutic index modeling.
• Champion cross-functional training, continuous improvement initiatives, and organizational readiness efforts to support growth, internal alignment, and regulatory preparedness (e.g., 21 CFR Part 11, GCP, ICH, NRC/EMA standards).
• Establish performance metrics and dashboards for radiation sciences support of clinical programs; report regularly to senior leadership on function performance, risks, and resource needs.

Qualifications

Education/Experience

• M.Sc. or Ph.D./D.Sc. in Medical Physics, Health Physics, Radiological Sciences, or closely related discipline.
• Board certification by the ABR or CCPM
• Minimum of 8-10 years of progressive experience in radiation oncology, nuclear medicine, or radiopharmaceutical development, including at least 3–5 years in a leadership or strategic oversight capacity (industry or academic/clinical leadership).
• Deep expertise in therapeutic and diagnostic dosimetry for radiopharmaceuticals, including hands-on and oversight-level experience with software such as OLINDA, MIM, Dosimetry Toolkit, or similar tools.
• Demonstrated experience supporting or leading clinical development programs in radioligand therapy or other nuclear medicine-based therapeutics, including contributions to clinical trial design, regulatory documentation, and cross-functional strategy.
• In-depth knowledge of regulatory frameworks and professional standards governing radiopharmaceuticals and medical physics (e.g., NRC, IAEA, EMA, FDA, SNMMI, AAPM).
• Proficiency in imaging informatics, including DICOM standards, PACS systems, and image data transfer and security, as well as experience with imaging protocol development and image quality assurance.
• Experience leading or supporting cross-site quality control programs and multi-center clinical trials involving radiological imaging and dosimetry components.

• Completion of a CAMPEP-accredited residency and/or advanced training in radiopharmaceutical dosimetry or imaging sciences.
• Prior experience in the biopharmaceutical or medical device industry, preferably within a GCP-compliant environment or in support of regulatory submissions (IND, CTA, NDA).
• Strong understanding of radiation biology, radiochemistry, and therapeutic index modeling.
• Experience working with early-phase through late-stage clinical development programs, and/or involvement in commercialization of radiopharmaceutical products.
• Recognized thought leadership in the field through scientific publications, conference presentations, or participation in relevant professional societies.

Knowledge / Skill / Ability

• Excellent verbal and written communication skills and collaborative interpersonal skills.
• Critical thinking, cause-and-effect reasoning, abductive reasoning, analogical reasoning, inductive reasoning, deductive reasoning.
• Strong executive presence with exceptional leadership, strategic vision, and decision-making capabilities.
• Outstanding collaboration, negotiation, and communication skills, with the ability to engage effectively with both internal and external stakeholders.
• Highly analytical and data-driven approach to clinical development and problem-solving.
• Proven ability to manage multiple complex programs and drive execution in a fast-paced, dynamic environment.
• Must be willing to travel up to 20% of the time, as measured on a calendar quarter. Both domestic and international travel may be required